title: Market Access Advancements and Challenges in "Drug-Companion Diagnostic Test" Co-Development in Europe.
abstract: The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. However, with several breakthroughs still in a nascent stage, market access becomes a crucial factor for commercial success, especially when it comes to co-creating value for pertinent stakeholders. This article highlights diverse issues from stakeholder perspectives in Europe, specifically the ones which require immediate resolution. Furthermore, the article also discusses case studies articulating potential solutions for the issues discussed.
authors.affiliation: Phamax Analytics Resources Pvt. Ltd. #19, KMJ Ascend 1st Cross, 17th C Main 5th Block, Koramangala Bangalore 560 095, India. ildar.akhmetov@phamax.ch.
authors.forename: Ildar
authors.initials: I
authors.lastname: Akhmetov
authors.affiliation: Phamax Analytics Resources Pvt. Ltd. #19, KMJ Ascend 1st Cross, 17th C Main 5th Block, Koramangala Bangalore 560 095, India. raksha.svr@gmail.com.
authors.forename: Rakshambikai
authors.initials: R
authors.lastname: Ramaswamy
authors.affiliation: Unicorn, POB 91, Zhytomyr 10020, Ukraine. ia@unicorn-exp.com.
authors.forename: Illias
authors.initials: I
authors.lastname: Akhmetov
authors.affiliation: Phamax Analytics Resources Pvt. Ltd. #19, KMJ Ascend 1st Cross, 17th C Main 5th Block, Koramangala Bangalore 560 095, India. phani.kishore@phamax.ch.
authors.forename: Phani Kishore
authors.initials: PK
authors.lastname: Thimmaraju
keywords: Stratified medicine; companion diagnostics; cost-effectiveness; market access; value addition